Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 230,468 | 235,637 | 228,031 | 253,155 | 225,110 |
| Cost of Goods | 64,404 | 62,682 | 55,093 | 63,701 | 39,374 |
| Gross Profit | 166,064 | 172,955 | 172,938 | 189,454 | 185,736 |
| Operating Expenses | 135,502 | 140,997 | 149,311 | 188,865 | 216,512 |
| Operating Income | 30,966 | 32,640 | 23,720 | 1,290 | -30,402 |
| Interest Expense | 12,452 | 13,330 | 11,592 | 12,807 | 14,046 |
| Other Income | 5,586 | 3,364 | -11,671 | -17,285 | -15,340 |
| Pre-tax Income | 24,100 | 22,674 | 457 | -28,802 | -59,788 |
| Income Tax | -6,178 | 1,083 | 455 | 324 | 207 |
| Net Income Continuous | 30,278 | 21,591 | 2 | -29,126 | -59,995 |
| Net Income | $30,278 | $21,591 | $2 | $-29,126 | $-59,995 |
| EPS Basic Total Ops | 0.62 | 0.46 | 0.00 | -0.72 | -1.52 |
| EPS Basic Continuous Ops | 0.62 | 0.46 | 0.00 | -0.72 | -1.52 |
| EPS Diluted Total Ops | 0.62 | 0.45 | 0.00 | -0.72 | -1.52 |
| EPS Diluted Continuous Ops | 0.62 | 0.45 | 0.00 | -0.72 | -1.52 |
| EPS Diluted Before Non-Recurring Items | 0.62 | 0.45 | 0.00 | -0.72 | -1.52 |
| EBITDA(a) | $42,490 | $44,159 | $33,560 | $12,595 | $-20,369 |